Does disseminated intravascular coagulation lead to multiple organ failure?

Critical Care Clinics

Volumn 21, Issue 3 SPEC. ISS., 2005, Pages 469-477

  Vincent, Jean Louis ^a   De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACTIVATED PROTEIN C; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTITHROMBIN; DROTRECOGIN; GLYCERYL TRINITRATE; HEPARIN; HIRUDIN; TISSUE FACTOR PATHWAY INHIBITOR;

ACUTE RESPIRATORY TRACT DISEASE; CELL INTERACTION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMOSTASIS; HUMAN; ISCHEMIA; LUNG INJURY; MICROTHROMBUS; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; THROMBOCYTOPENIA;

EID: 21244449212     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2005.04.002     Document Type: Review

References (50)

1. F.B. Taylor Jr, C.H. Toh, and W.K. Hoots Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
2. P. Thorborg Bleeding and thrombosis problems in critical care patients: an update Crit Care Shock 1 2000 4 20
3. M. Levi Current understanding of disseminated intravascular coagulation Br J Haematol 124 2004 567 576
4. A. Amaral, S.M. Opal, and J.L. Vincent Coagulation in sepsis Intensive Care Med 30 2004 1032 1040
5. S.M. Opal, and C.T. Esmon Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis Crit Care 7 2003 23 38
6. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
7. S. Akca, P. Haji-Michael, and A. de Mendonça The time course of platelet counts in critically ill patients Crit Care Med 30 2002 753 756
8. A.C. Mavrommatis, T. Theodoridis, and A. Orfanidou Coagulation system and platelets are fully activated in uncomplicated sepsis Crit Care Med 28 2000 451 457
9. S. Vanderschueren, A. De Weerdt, and M. Malbrain Thrombocytopenia and prognosis in intensive care Crit Care Med 28 2000 1871 1876
10. M. Gawaz, S. Fateh-Moghadam, and G. Pilz Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure Eur J Clin Invest 25 1995 843 851
11. A. Yaguchi, F.L. Lobo, and J.L. Vincent Platelet function in sepsis J Thromb Haemost 2 2004 2096 2102
12. S. Gando, T. Kameue, and S. Nanzaki Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome Thromb Haemost 75 1996 224 228
13. S. Gando, S. Nanzaki, and O. Kemmotsu Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis Ann Surg 229 1999 121 127
14. S. Gando, T. Kameue, and N. Matsuda Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma Thromb Haemost 88 2002 943 949
15. F. Fourrier, C. Chopin, and J. Goudemand Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies Chest 101 1992 816 823
16. C.H. Toh, and C. Downey Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation Blood Coagul Fibrinolysis 16 2005 69 74
17. J.F. Dhainaut, S.B. Yan, and D.E. Joyce Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J Thromb Haemost 2 2004 1924 1933
18. K. Bakhtiari, J.C. Meijers, and E. de Jonge Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2004 2416 2421
19. J.A. Gebbia, J.C. Monco, and J.L. Degen The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis J Clin Invest 103 1999 81 87
20. O.A. Sodeinde, Y.V. Subrahmanyam, and K. Stark A surface protease and the invasive character of plague Science 258 1992 1004 1007
21. T.E. Bucknall The effect of local infection upon wound healing: an experimental study Br J Surg 67 1980 851 855
22. Y. Shibayama Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury J Pathol 151 1987 315 321
23. S. Asaka, Y. Shibayama, and K. Nakata Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo Liver 16 1996 183 187
24. W. Margaretten Local tissue damage in disseminated intravascular clotting Am J Cardiol 20 1967 185 190
25. T. Yoshikawa, K.R. Tanaka, and L.B. Guze Infection and disseminated intravascular coagulation Medicine (Baltimore) 50 1971 237 258
26. M. Kojima, K. Shimamura, and N. Mori A histological study on microthrombi in autopsy cases of DIC Bibl Haematol 49 1983 95 106
27. S.C. Stein, D.I. Graham, and X.H. Chen Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury Neurosurgery 54 2004 687 691
28. M.C. McHenry, A.H. Baggenstoss, and W.J. Martin Bacteremia due to gram-negative bacilli: clinical and autopsy findings in 33 cases Am J Clin Pathol 50 1968 160 174
29. R. Greene, W.M. Zapol, and M.T. Snider Early bedside detection of pulmonary vascular occlusion during acute respiratory failure Am Rev Respir Dis 124 1981 593 601
30. S. Vesconi, G.P. Rossi, and A. Pesenti Pulmonary microthrombosis in severe adult respiratory distress syndrome Crit Care Med 16 1988 111 113
31. Z.F. Huang, D. Higuchi, and N. Lasky Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice Blood 90 1997 944 951
32. A.A. Creasey, A.C. Chang, and L. Feigen Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock J Clin Invest 91 1993 2850 2856
33. C. Carr, G.S. Bild, and A.C. Chang Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram- negative model of septic shock Circ Shock 44 1994 126 137
34. E. Abraham, K. Reinhart, and S. Opal Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial JAMA 290 2003 238 247
35. F.B.J. Taylor, T.E.J. Emerson, and R. Jordan Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons Circ Shock 26 1988 227 235
36. B.L. Warren, A. Eid, and P. Singer Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 2001 1869 1878
37. V. DePalo, C. Kessler, and S.M. Opal Success or failure in phase III sepsis trials: comparisons between the Drotrecogin alfa (activated) and antithrombin III clinical trials Adv Sepsis 1 2001 114 124
38. L.O. Mosnier, A.J. Gale, and S. Yegneswaran Activated protein C variants with normal cytoprotective but reduced anticoagulant activity Blood 104 2004 1740 1744
39. J.F. Dhainaut, and J. Charpentier CIVD et défaillance d'organes: arguments expérimentaux et cliniques Réanimation 11 2002 599 607
40. G. Cirino, C. Napoli, and M. Bucci Inflammation-coagulation network: are serine protease receptors the knot? Trends Pharmacol Sci 21 2000 170 172
41. J.M. Harlan, and R.K. Winn Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy Crit Care Med 30 5 Suppl 2002 S214 S219
42. J.A. Nick, C.D. Coldren, and M.W. Geraci Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis Blood 104 2004 3878 3885
43. Z. Balogh, A. Wolfard, and L. Szalay Dalteparin sodium treatment during resuscitation inhibits hemorrhagic shock-induced leukocyte rolling and adhesion in the mesenteric microcirculation J Trauma 52 2002 1062 1069
44. J.N. Hoffmann, B. Vollmar, and M.W. Laschke Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms Thromb Haemost 88 2002 242 252
45. J.N. Hoffmann, B. Vollmar, and M.W. Laschke Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia Crit Care Med 32 2004 1011 1017
46. J.N. Hoffmann, B. Vollmar, and J. Romisch Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium Crit Care Med 30 2002 218 225
47. J.N. Hoffmann, B. Vollmar, and D. Inthorn The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure Shock 14 2000 528 534
48. D. De Backer, J. Creteur, and J.C. Preiser Microvascular blood flow is altered in patients with sepsis Am J Respir Crit Care Med 166 2002 98 104
49. Y. Sakr, M.J. Dubois, and D. De Backer Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock Crit Care Med 32 2004 1825 1831
50. P.E. Spronk, C. Ince, and M.J. Gardien Nitroglycerin in septic shock after intravascular volume resuscitation Lancet 360 2002 1395 1396